Related Experiment Video

Updated: Aug 8, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy

Sho-ichi Yamagishi1, Kazuo Nakamura, Takanori Matsui

  • 1Department of Internal Medicine III, Kurume University School of Medicine, Kurume 830-0011, Japan. shoichi@med.kurume-u.ac.jp

Current Drug Discovery Technologies
|May 23, 2006
PubMed

Insights

Diabetic vascular complications, including retinopathy, are linked to advanced glycation end products (AGEs) and their receptor (RAGE). Inhibiting the AGE-RAGE system offers a promising therapeutic target.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Ophthalmology

Background:

  • Diabetic vascular complications contribute significantly to morbidity and mortality.
  • Advanced glycation end products (AGEs) accumulate rapidly in diabetes, driving pathogenesis.
  • The receptor for AGEs (RAGE) interaction triggers inflammatory responses in vascular cells.

Purpose of the Study:

  • To review the molecular mechanisms of diabetic retinopathy.
  • To focus on the role of the AGE-RAGE system in diabetic retinopathy.
  • To discuss inhibitors of the AGE-RAGE system and their therapeutic potential.

Main Methods:

  • Literature review of molecular mechanisms.
  • Focus on the AGE-RAGE signaling pathway.
  • Analysis of therapeutic interventions targeting AGE-RAGE.

Main Results:

  • AGEs and RAGE are implicated in diabetic vascular complications, including retinopathy.
  • AGE-RAGE interaction activates inflammatory signaling in vascular cells.
  • Inhibiting AGE formation or RAGE signaling shows therapeutic promise.

Conclusions:

  • The AGE-RAGE system is a key player in diabetic retinopathy pathogenesis.
  • Targeting the AGE-RAGE pathway represents a viable strategy for preventing diabetic vascular complications.
  • Further research into AGE-RAGE inhibitors is warranted for clinical application.

More Related Videos

Retinal Pathophysiological Evaluation in a Rat Model09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...